Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Schwartz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2009
Current combination chemotherapy regimens for metastatic breast cancerJoanna Schwartz
Journal of American College Health : J of ACH|July 27, 2021
NCHA variable combination as a method to undertake LGBTQ + student subpopulation analysesJoanna Schwartz, Whitney Ginder
Pediatric Emergency Care|June 1, 2018
An Anaphylactoid Reaction to Rattlesnake Envenomation in a Pediatric PatientLogan Rencher, Joanna Schwartz, Alexandra Wilson
Surgical Oncology Clinics of North America|August 30, 2008
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastasesDon S Dizon, Joanna Schwartz, Nancy Kemeny
Gynecologic Oncology|April 11, 2009
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2Joanna Schwartz, Beth Toste, Don S Dizon
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal cancer?Carolyn McCourt, Sybil Dessie, Ann Marie Bradley, et al.
Gynecologic Oncology|February 24, 2006
Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicinMary E Gordinier, Don S Dizon, Evelyn L Fleming, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 9, 2008
Effects of chemotherapy during pregnancy on the placentaRosanna G Abellar, John R Pepperell, David Greco, et al.
Gynecologic Oncology|October 4, 2005
Cross-sensitivity between paclitaxel and docetaxel in a women's cancers programDon S Dizon, Joanna Schwartz, Adam Rojan, et al.
Gynecologic Oncology|December 13, 2005
Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancerDon S Dizon, Sherry Weitzen, Adam Rojan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2009
Current combination chemotherapy regimens for metastatic breast cancerJoanna Schwartz
Journal of American College Health : J of ACH|July 27, 2021
NCHA variable combination as a method to undertake LGBTQ + student subpopulation analysesJoanna Schwartz, Whitney Ginder
Pediatric Emergency Care|June 1, 2018
An Anaphylactoid Reaction to Rattlesnake Envenomation in a Pediatric PatientLogan Rencher, Joanna Schwartz, Alexandra Wilson
Surgical Oncology Clinics of North America|August 30, 2008
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastasesDon S Dizon, Joanna Schwartz, Nancy Kemeny
Gynecologic Oncology|April 11, 2009
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2Joanna Schwartz, Beth Toste, Don S Dizon
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal cancer?Carolyn McCourt, Sybil Dessie, Ann Marie Bradley, et al.
Gynecologic Oncology|February 24, 2006
Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicinMary E Gordinier, Don S Dizon, Evelyn L Fleming, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 9, 2008
Effects of chemotherapy during pregnancy on the placentaRosanna G Abellar, John R Pepperell, David Greco, et al.
Gynecologic Oncology|October 4, 2005
Cross-sensitivity between paclitaxel and docetaxel in a women's cancers programDon S Dizon, Joanna Schwartz, Adam Rojan, et al.
Gynecologic Oncology|December 13, 2005
Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancerDon S Dizon, Sherry Weitzen, Adam Rojan, et al.
Pageof 1